Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN7 | P35236 | 5/20 | 0.56 |
| ▸ | HMGCR | P04035 | 2/20 | 0.56 |
| ▸ | RECQL | P46063 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL290566 | 0.96 | PTPN7 (0.61) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL11175213 | 0.96 | PTPN7 (0.61) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL513302 | 0.96 | PTPN7 (0.61) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL11066113 | 0.96 | PTPN7 (0.61) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL10796010 | 0.96 | PTPN7 (0.61) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL23040316 | 0.96 | PTPN7 (0.61) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL9211891 | 0.96 | PTPN7 (0.61) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL9374800 | 0.96 | PTPN7 (0.61) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL1523678 | 0.96 | PTPN7 (0.61) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL11071774 | 0.96 | PTPN7 (0.61) | PTPN7HMGCRRECQLTDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260130860-A1 | LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS | FLAGSHIP LABS 114, INC. (US) | 2026-05-14 | — | — | US | claimed |
| EP-4687854-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | Flagship Labs 114, Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| WO-2024211865-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | OMEGA THERAPEUTICS, INC. (US) | 2024-10-10 | — | — | WO | claimed |
| US-20240339358-A1 | METHOD OF FORMING A METAL LINER FOR INTERCONNECT STRUCTURES | APPLIED MATERIALS, INC. (US) | 2024-10-10 | — | — | US | claimed |
| WO-2024211169-A1 | METHOD OF FORMING A METAL LINER FOR INTERCONNECT STRUCTURES | APPLIED MATERIALS, INC. (US) | 2024-10-10 | — | — | WO | claimed |
| WO-2024073678-A2 | PHOSPHOLIPIDS CONTAINING A HETEROCYCLE RING HAVING A TERTIARY AMINE OR AMIDE | OMEGA THERAPEUTICS, INC. (US) | 2024-04-04 | — | — | WO | claimed |
| WO-2023225621-A2 | LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS | OMEGA THERAPEUTICS, INC. (US) | 2023-11-23 | — | — | WO | claimed |
| US-20230167139-A1 | PHOTOCHROMIC GERMOLE-FUSED DIARYLETHENES AND PRODUCTION THEREOF | THE UNIVERSITY OF HONG KONG (CN) | 2023-06-01 | — | — | US | claimed |
| CN-107074886-B | Stable photochromic compounds having silicon-or phosphorus-containing heterocycles and process for their production | 香港大学 | 2020-09-15 | — | — | CN | claimed |
| US-9708528-B2 | Robust photochromic compounds with silicon- or phosphorus-containing heterocyclic ring and the production thereof | THE UNIVERSITY OF HONG KONG (HK) | 2017-07-18 | — | — | US | claimed |
| US-20150361332-A1 | ROBUST PHOTOCHROMIC COMPOUNDS WITH SILICON- OR PHOSPHORUS-CONTAINING HETEROCYCLIC RING AND THE PRODUCTION THEREOF | THE UNIVERSITY OF HONG KONG (HK) | 2015-12-17 | — | — | US | claimed |
| US-8436118-B2 | Synthesis of acylarylenes and hyperbranched poly(aclarylene)s by metal-free cyclotrimerization of alkynes | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2013-05-07 | — | — | US | claimed |
| CN-102964317-A | New preparation method of tetrasubstituted furan compound | DALIAN CHEMICAL PHYSICS INST | 2013-03-13 | — | — | CN | claimed |
| EP-2181763-B1 | Catalyst and process for alkoxylation | SHELL INT RESEARCH (NL) | 2012-06-20 | — | — | EP | claimed |
| US-20100129757-A1 | SYNTHESIS OF ACYLARYLENES AND HYPERBRANCHED POLY(ACLARYLENE)S BY METAL-FREE CYCLOTRIMERIZATION OF ALKYNES | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2010-05-27 | — | — | US | claimed |
| WO-2008151499-A1 | SYNTHESIS OF ACYLARYLENES AND HYPERBRANCHED POLY(ACYLARYLENE)S BY METAL-FREE CYCLOTRIMERIZATION OF ALKYNES | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2008-12-18 | — | — | WO | claimed |
| EP-4748965-A2 | FORMULATIONS FOR SELECTIVE DEPOSITION | Merck Patent GmbH (DE) | 2026-05-27 | — | — | EP | disclosed |
| EP-4743602-A1 | FORMULATIONS FOR SELECTIVE DEPOSITION | Merck Patent GmbH (DE) | 2026-05-20 | — | — | EP | disclosed |
| US-4061772-A | HYPOURICEMIC, URICOSURIC, HYPOLIPIDEMIC | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-12-06 | — | — | US | disclosed |
| US-4001431-A | DERIVATIVES OF THE 1,2-DIARYLETHYLENE- AND PHARMACEUTICAL COMPOSITIONS THEREOF | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260130860-A1 | LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS | NSUN3, NSUN2, LDLR | PTPN7 2194/4885HMGCR 460/4885RECQL 976/4885 |
| US-20150361332-A1 | ROBUST PHOTOCHROMIC COMPOUNDS WITH SILICON- OR PHOSPHORUS-CONTAINING HETEROCYCLIC RING AND THE PRODUCTION THEREOF | CRY1, CRY2, P2RY10 | PTPN7 1941/4885HMGCR 4665/4885RECQL 789/4885 |
| US-20230167139-A1 | PHOTOCHROMIC GERMOLE-FUSED DIARYLETHENES AND PRODUCTION THEREOF | AGL, GMNN, GAK | PTPN7 3021/4885HMGCR 4231/4885RECQL 97/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.